Revolution Medicines Total Long Term Liabilities 2018-2024 | RVMD

Revolution Medicines total long term liabilities for the quarter ending September 30, 2024 were $0.086B, a 40.17% increase year-over-year.

  • Revolution Medicines total long term liabilities for 2023 were $0.092B, a 41.54% increase from 2022.
  • Revolution Medicines total long term liabilities for 2022 were $0.065B, a 13.74% decline from 2021.
  • Revolution Medicines total long term liabilities for 2021 were $0.075B, a 64.81% increase from 2020.

Revolution Medicines Total Long Term Liabilities 2018-2024 | RVMD

  • Revolution Medicines total long term liabilities for 2023 were $0.092B, a 41.54% increase from 2022.
  • Revolution Medicines total long term liabilities for 2022 were $0.065B, a 13.74% decline from 2021.
  • Revolution Medicines total long term liabilities for 2021 were $0.075B, a 64.81% increase from 2020.